Биржевая цена
4.15
Изменение за день
0.19 4.80%
Ежемесячно
26.14%
Ежегодный
133.15%
Q2 прогноз
3.85




Рыночная капитализация Изменить Дата
AbbVie USD 403.83B 5.2B 2025-12
Agenus USD 107M 16M 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Celldex Therapeutics USD 1.81B 87M 2025-12
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Glaxosmithkline GBP 99.93B 13.05B 2025-12
Incyte USD 19.39B 2.83B 2025-12
J&J USD 500.24B 67.44B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
MacroGenics USD 102M 4M 2025-12
Merck EUR 53.3B 5.72B 2025-12
Merck USD 261.26B 51.62B 2025-12
Northwest Biotherapeutics USD 246M 110M 2026-04
Novartis USD 292.21B 26.55B 2025-12
Novavax USD 1.09B 316M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Veracyte USD 3.33B 627M 2025-12